Profil
Kevin Chen is associated with the firm Hyasynth Biologicals, Inc. as the Chief Executive Officer since 2014.
He is the founder of the company which was also founded in 2014.
Postes actifs de Kevin Chen
| Sociétés | Poste | Début |
|---|---|---|
Hyasynth Biologicals, Inc.
 Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | Directeur Général | 01/01/2014 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Hyasynth Biologicals, Inc.
Hyasynth Biologicals, Inc. BiotechnologyHealth Technology Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada. | Health Technology |
